Changsheng Life Sciences declared bankrupt in vaccine scandal

Published On 2019-11-13 03:30 GMT   |   Update On 2019-11-13 03:30 GMT

Changsheng Life Sciences used expired materials, mixed different batches of products and failed to test them properly, according to regulators. They said the company destroyed records to conceal its misconduct.


New Delhi: A Chinese maker of rabies vaccine that was fined 9.1 billion yuan (USD 1.3 billion) in a product quality scandal that set off a crackdown on the industry said Friday it has been declared bankrupt. Changchun Changsheng Life Sciences Ltd., which lost its production licenses last year, said in a statement that a court issued the ruling after concluding the company was insolvent and couldn't pay its debts.


Revelations that authorities failed to act immediately after finding the company might have falsified production records led to an outcry among a public already upset over deaths and injuries due to fake or shoddy medicines, milk, toys and other products.


Changsheng Life Sciences used expired materials, mixed different batches of products and failed to test them properly, according to regulators. They said the company destroyed records to conceal its misconduct.


Read Also: Fight against Rabies: India hands over 10k vials of anti-rabies vaccines to Myanmar


The country's No 2 leader, Premier Li Keqiang, said the company "violated a moral bottom line." No injuries were reported but authorities recalled the company's products from China and foreign markets.


Rabies is endemic in parts of China.


Read Also: GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News